Full Library
Antifungal Susceptibility of Emerging Dimorphic Pathogens in the Family Ajellomycetaceae
Resource type
Journal Article
Authors/contributors
- Dukik, Karolina (Author)
- Al-Hatmi, Abdullah M. S. (Author)
- Curfs-Breuker, Ilse (Author)
- Faro, Dirk (Author)
- de Hoog, Sybren (Author)
- Meis, Jacques F. (Author)
Title
Antifungal Susceptibility of Emerging Dimorphic Pathogens in the Family Ajellomycetaceae
Abstract
The in vitro susceptibilities of 24 molecularly identified dimorphic fungi belonging to the genera Adiaspiromyces, Blastomyces, and Emergomyces within the family Ajellomycetaceae were tested against 8 standard antifungal agents using CLSI document M38-A2. Amphotericin B and posaconazole had the lowest geometric mean MICs (<0.05 μg/ml) followed by itraconazole (<0.07 μg/ml), voriconazole (<0.15 μg/ml), and isavuconazole (<0.42 μg/ml) while fluconazole was not active. Micafungin demonstrated good in vitro antifungal activity against Emergomyces (geometric mean minimum effective concentration [GM MEC] 0.1 μg/ml) and Blastomyces (GM MEC <0.017 μg/ml).
Publication
Antimicrobial Agents and Chemotherapy
Date
2017-12-21
Volume
62
Issue
1
Pages
e01886-17
Journal Abbr
Antimicrob Agents Chemother
Accessed
6/6/22, 3:51 PM
ISSN
0066-4804
Library Catalog
PubMed Central
Extra
PMID: 29084748
PMCID: PMC5740316
Citation
Dukik, K., Al-Hatmi, A. M. S., Curfs-Breuker, I., Faro, D., de Hoog, S., & Meis, J. F. (2017). Antifungal Susceptibility of Emerging Dimorphic Pathogens in the Family Ajellomycetaceae. Antimicrobial Agents and Chemotherapy, 62(1), e01886-17. https://doi.org/10.1128/AAC.01886-17
Link to this record